Semotiadil

This classification denotes a calcium channel blocker, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DGN08QZ30G. European Medicines Agency schedules Semotiadil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10481MIG. Semotiadil generally arises in the molecular formula C29H32N2O6S. The term SEMOTIADIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) SEMOTIADIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule semotiadil under HS 29349990 and SITC 51579. As of Q4 2014, SEMOTIADIL remains the US FDA Preferred Term for this commodity. Semotiadil bears US NLM identifiers UMLS ID C0084530 and NCI Concept Code C72624. SMILES: S1C(c2c(OCCCN(CCOc3cc4OCOc4cc3)C)ccc(OC)c2)C(=O)N(c2c1cccc2)C.